Copertina

NSD2 targeting reverses plasticity and drug resistance in prostate cancer.

Fuente: PubMed

Salvato in:

Dettagli Bibliografici
Autori principali:	Li, Jia J, Vasciaveo, Alessandro, Karagiannis, Dimitris, Sun, Zhen, Gretarsson, Kristjan H, Chen, Xiao, Ouerfelli, Ouathek, Socciarelli, Fabio, Frankenstein, Ziv, Dong, Hanyang, Zou, Min, Yuan, Wei, Yang, Guangli, Aizenman, Gabriel M, Pannellini, Tania, Xu, Xinjing, Beltran, Himisha, Chen, Yu, Gardner, Kevin, Robinson, Brian D, de Bono, Johann, Gozani, Or, Abate-Shen, Cory, Rubin, Mark A, Loda, Massimo, Sawyers, Charles L, Califano, Andrea, Lu, Chao, Shen, Michael M
Natura:	Artículo científico
Lingua:	en
Pubblicazione:	Nature 2026
Soggetti:	Male Humans Animals Mice Drug Resistance, Neoplasm Prostatic Neoplasms, Castration-Resistant Benzamides Phenylthiohydantoin Histone-Lysine N-Methyltransferase Receptors, Androgen Nitriles Cell Line, Tumor Organoids Cell Plasticity Repressor Proteins Histones Cell Transdifferentiation Methylation Up-Regulation Adenocarcinoma Gene Expression Regulation, Neoplastic
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Supplementary data for "The histone code of love: epigenetics of maturation of gonads in the human blood fluke Schistosoma mansoni"
di: Grunau, Christoph
Pubblicazione: (2026)

KDM5C: A dual-edged epigenetic regulator in cancer biology-context-dependent roles and therapeutic implications.
di: Tu, Fei-Yang, et al.
Pubblicazione: (2025)

BIT1 as an Effector of EGFR-TKI-induced Apoptosis TLE1 Inhibition in Lung Adenocarcinoma Cells.
di: Dela Cruz, Ma Carmela, et al.
Pubblicazione: (2026)

Dual modes of DNA N-methyladenine maintenance by distinct methyltransferase complexes.
di: Wang, Yuanyuan, et al.
Pubblicazione: (2025)

Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy.
di: Baurès, Manon, et al.
Pubblicazione: (2026)

PIF/harbinger transposon-derived protein promotes 7SL expression to enhance pathogen resistance.
di: Geng, Shang, et al.
Pubblicazione: (2025)

Discovery of the First-in-Class Dual-Target ROCK/HDAC Inhibitor with Potent Antitumor Efficacy in Vivo That Trigger Antitumor Immunity.
di: Mao, Churu, et al.
Pubblicazione: (2024)

Patient-derived organoids predict chemotherapy response of locally advanced gastric cancer.
di: Huang, Miao, et al.
Pubblicazione: (2026)

Apigenin Induces Autophagy and Apoptosis in Chemoresistant Glioblastoma Cells and Inhibits Tumorigenicity Associated with Regulation of Immunomodulatory Proteins and Glial Cells Response.
di: Coelho, Paulo Lucas Cerqueira, et al.
Pubblicazione: (2025)

Clinical and pathological prognostic factors for prostate cancer progression to a castration resistant disease
di: Ahmed Abdul, Hussein Attyia, et al.
Pubblicazione: (2024)

Tumor-associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers.
di: Song, No-Joon, et al.
Pubblicazione: (2025)

Anticancer activity of triterpene glycosides from the sea star Solaster pacificus.
di: Dyshlovoy, Sergey A, et al.
Pubblicazione: (2025)

Distal enhancer RNAs regulate alternative promoter usage of MYB and drug resistance in human leukemia cells.
di: Wang, Yucheng, et al.
Pubblicazione: (2026)

Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.
di: Mzoughi, Slim, et al.
Pubblicazione: (2025)

Bromodomain-containing proteins in the unicellular eukaryote .
di: Zhang, Zhe, et al.
Pubblicazione: (2025)

Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response.
di: Xiong, Jieyi, et al.
Pubblicazione: (2025)

Diphenyl Disulfide Induces Nonapoptotic Paraptosis in Breast Cancer Cells via ROS-Mediated ER Stress.
di: Chen, Sheng-Yuan, et al.
Pubblicazione: (2026)

Low-molecular-weight polyphenol promotes cell sensitivity to cisplatin and alleviates cancer-related muscle atrophy via NF-κB suppression in oral squamous cell carcinoma.
di: Chang, Yun-Ching, et al.
Pubblicazione: (2025)

Natural and Artificial Hematopoietic Cell Reprogramming.
di: Yu, Dong, et al.
Pubblicazione: (2026)

Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells.
di: Zhang, Yunfang, et al.
Pubblicazione: (2024)

Ulvan derived from Ulva lactuca suppresses hepatocellular carcinoma cell proliferation through miR-542-3p-mediated downregulation of SLC35F6.
di: Qiu, Yinghui, et al.
Pubblicazione: (2025)

Direct lysine dimethylation of IRF3 by the methyltransferase SMYD3 attenuates antiviral innate immunity.
di: Wang, Zixuan, et al.
Pubblicazione: (2025)

Effects of N-Acetylcysteine and Alpha-Ketoglutarate on OVCAR3 Ovarian Cancer Cells: Insights from Integrative Bioinformatics and Experimental Validation.
di: Khamineh, Yasaman, et al.
Pubblicazione: (2026)

Discovery of unique mitotic mechanisms in .
di: Akiyoshi, Bungo, et al.
Pubblicazione: (2025)

FZD7 expression marks mammary tumor-initiating cells.
di: Wu, Christina C N, et al.
Pubblicazione: (2025)

Antiproliferative and apoptotic effects of (1R*,12R*)-dolabella-4(16),7,10-triene-3,13-dione (CI-A) in oral cancer cells are mediated by oxidative stress and ERK activation.
di: Chuang, Ya-Ting, et al.
Pubblicazione: (2025)

Marine-derived peptides from Rapana venosa inhibit breast cancer cell growth through synergistic mechanisms with doxorubicin.
di: Saleh, Mai A, et al.
Pubblicazione: (2025)

Expression of ALG8 in hepatocellular carcinoma and its diagnostic and prognostic significance.
di: Haishen, Yang, et al.
Pubblicazione: (2025)

NF-kappa-B inhibitor alpha mediates cancer stemness characteristics in oral squamous cell carcinoma by interacting with cathepsin B.
di: Qin, Tian Xu, et al.
Pubblicazione: (2025)

A Physical Framework to Control Cancer Cell Heterogeneity and Plasticity.
di: De Blander, Hadrien, et al.
Pubblicazione: (2026)

Bromodomain protein IBD1 bridges histone acetylation and H2A.Z deposition to fine-tune transcription.
di: Zhang, Zhe, et al.
Pubblicazione: (2026)

Heteronemin suppresses EGF‑induced proliferation through the PI3K/PD‑L1 signaling pathways in cholangiocarcinoma.
di: Yang, Yu-Chen S H, et al.
Pubblicazione: (2025)

Potential anticancer properties of Tetraselmis suecica extract against oral and colorectal cancer cells.
di: Asoudeh-Fard, Abbas, et al.
Pubblicazione: (2025)

The functional role of LncRNA HOXA-AS2 in multiple human cancers.
di: Khoshandam, Mohadeseh, et al.
Pubblicazione: (2025)

Clear cell variant of oral squamous cell carcinoma: case report and review
di: Rutuja Narsing Mukkanwar
Pubblicazione: (2022)

H3K27me3 spreading organizes canonical PRC1 chromatin architecture to regulate developmental programs.
di: Krug, Brian, et al.
Pubblicazione: (2026)

Design, synthesis, and biological evaluation of N-(2-amino-phenyl)-5-(4-aryl- pyrimidin-2-yl) amino)-1H-indole-2-carboxamide derivatives as novel inhibitors of CDK9 and class I HDACs for cancer treatment.
di: Chen, Xiaohui, et al.
Pubblicazione: (2025)

KHSRP protects colorectal cancer cells against ferroptosis by regulating GPX4 expression through interaction with hnRNPM.
di: Ding, Xia, et al.
Pubblicazione: (2025)

PSPC1 knockout promotes radiosensitivity, inhibits EMT, and metastasis of nasopharyngeal carcinoma cells.
di: He, Huocong, et al.
Pubblicazione: (2025)

Cereblon upregulation overcomes thalidomide resistance in multiple myeloma through mitochondrial functional reprogramming.
di: Marquez, Jubert, et al.
Pubblicazione: (2026)